Heron Therapeutics

Verified by our team

  • Research
Linkedin Twitter Facebook

Heron Therapeutics aims to enhance patient care with best-in-class therapies that deliver impactful medicines. Utilizing its proprietary Biochronomer™ drug delivery platform, Heron converts injectable drugs from daily to weekly or bi-weekly dosing, improving therapeutic outcomes.

Heron Therapeutics Highlights:

  • Heron Therapeutics annual revenue is $136.4M.
  • Heron Therapeutics total funding is $1.6B.
  • Heron Therapeutics headquartered in San Diego, California.
  • Heron Therapeutics number of employees is 180.

    • Overview

    • Website: herontx.com
    • Headquarters: San Diego, California
    • Employees: 180
    • Founded: 1983
    • Email: info@herontx.com
    • Funding: $1.6B
    • Revenue: $136.4M
    • Valuation: n/a

    Contacts

    Craig Collard

    CEO
    Linkedin
    • Email: ***@herontx.com
    Buy the List to Unlock Contacts

    Similar companies

    Frequently Asked Questions related to Heron Therapeutics

    Heron Therapeutics is located in San Diego, California.
    Yes, Heron Therapeutics is a Silicon Valley company.
    Heron Therapeutics total funding is 1.6B.
    Heron Therapeutics revenue is 136.4M.
    Heron Therapeutics’s number of employees is 180.
    Heron Therapeutics’s CEO name is Craig Collard.
    Heron Therapeutics was founded in 1983.
    Heron Therapeutics’s contact email is info@herontx.com.

    Follow Silicon Valley Journals

    Awarded by

    corporate vision magazine

    © Copyright 2022-2024 Silicon Valley Journals. All rights reserved.

    Fundings

    Quick links

    Company

    © Copyright SVJ Media Ltd., 71-75 Shelton Street. Covent Garden. London, GB WC2H 9JQ